TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Miltenyi Biotec Norden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
152,812
|
122,608
|
102,168 |
Financial expenses |
1
|
19
|
1 |
Earnings before taxes |
11,062
|
11,579
|
8,419 |
EBITDA |
13,299
|
12,800
|
9,211 |
Total assets |
63,409
|
50,305
|
52,509 |
Current assets |
55,245
|
42,999
|
49,993 |
Current liabilities |
43,589
|
39,867
|
31,595 |
Equity capital |
19,820
|
10,437
|
20,914 |
- share capital |
51
|
47
|
49 |
Employees (average) |
22
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
31.3%
|
20.7%
|
39.8% |
Turnover per employee |
6,946
|
6,453
|
5,676 |
Profit as a percentage of turnover |
7.2%
|
9.4%
|
8.2% |
Return on assets (ROA) |
17.4%
|
23.1%
|
16.0% |
Current ratio |
126.7%
|
107.9%
|
158.2% |
Return on equity (ROE) |
55.8%
|
110.9%
|
40.3% |
Change turnover |
21,504
|
23,511
|
9,963 |
Change turnover % |
16%
|
24%
|
11% |
Chg. No. of employees |
3
|
1
|
3 |
Chg. No. of employees % |
16%
|
6%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.